GORMAN KEVIN CHARLES sold NBIX
January 31, 2026 · Form 4 insider transaction
GORMAN KEVIN CHARLES sold 2,845 shares of Neurocrine Biosciences, Inc. at $136.06 per share, a transaction worth $387.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,845
Price
$136.06
Total value
$387.1K
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after516,893
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of restricted stock units ("RSUs"). No shares were sold.; 516,893 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.